Division of Rheumatology, Allergy, and Clinical Immunology, University of California Davis, Davis, CA 95616, USA.
Hepatology. 2011 Jul;54(1):196-203. doi: 10.1002/hep.24355.
A major enigma of primary biliary cirrhosis (PBC) is the selective targeting of biliary cells. Our laboratory has reported that after apoptosis, human intrahepatic biliary epithelial cells (HiBECs) translocate the E2 subunit of the pyruvate dehydrogenase complex immunologically intact into apoptotic bodies, forming an apotope. However, the cell type and specificity of this reaction has not been fully defined. To address this issue, we investigated whether the E2 subunit of the pyruvate dehydrogenase complex, the E2 subunit of the branched chain 2-oxo acid dehydrogenase complex, the E2 subunit of the oxo-glutarate dehydrogenase complex, four additional inner mitochondrial enzymes, and four nuclear antigens remain immunologically intact with respect to postapoptotic translocation in HiBECs and three additional control epithelial cells. We report that all three 2-oxo acid dehydrogenase enzymes share the ability to remain intact within the apotope of HiBECs. Interestingly, the E2 subunit of the branched chain 2-oxo acid dehydrogenase complex also remained intact in the other cell types tested. We extended the data, using sera from 95 AMA-positive and 19 AMA-negative patients with PBC and 76 controls, by testing for reactivity against the seven mitochondrial proteins studied herein and also the ability of AMA-negative sera to react with HiBEC apotopes. Sera from 3 of 95 AMA-positive sera, but none of the controls, reacted with 2,4-dienoyl coenzyme A reductase 1, an enzyme also present intact only in the HiBEC apotope, but which has not been previously associated with any autoimmune disease. Finally, the specificity of HiBEC apotope reactivity was confined to AMA-positive sera.
We submit that the biliary specificity of PBC is secondary to the unique processes of biliary apoptosis.
原发性胆汁性肝硬化 (PBC) 的一个主要谜团是胆汁细胞的选择性靶向。我们的实验室报告称,在细胞凋亡后,人肝内胆管上皮细胞 (HiBECs) 将丙酮酸脱氢酶复合物的 E2 亚基免疫完整地转移到凋亡小体中,形成一个抗原表位。然而,这种反应的细胞类型和特异性尚未完全确定。为了解决这个问题,我们研究了丙酮酸脱氢酶复合物的 E2 亚基、支链 2-氧酸脱氢酶复合物的 E2 亚基、α-酮戊二酸脱氢酶复合物的 E2 亚基、另外四种线粒体内部酶以及四种核抗原在 HiBECs 和另外三种对照上皮细胞中的凋亡后易位是否仍然具有免疫完整性。我们报告说,所有三种 2-氧酸脱氢酶都具有在 HiBECs 的抗原表位中保持完整的能力。有趣的是,支链 2-氧酸脱氢酶复合物的 E2 亚基在测试的其他细胞类型中也保持完整。我们使用来自 95 名 AMA 阳性和 19 名 AMA 阴性 PBC 患者以及 76 名对照者的血清扩展了数据,通过测试对本文研究的七种线粒体蛋白的反应性以及 AMA 阴性血清与 HiBEC 抗原表位反应的能力。在 3 份 AMA 阳性血清中,但在对照组中没有,有 3 份 AMA 阳性血清与 2,4-二烯酰辅酶 A 还原酶 1 反应,这种酶也仅存在于 HiBEC 抗原表位中,但以前与任何自身免疫性疾病无关。最后,HiBEC 抗原表位反应的特异性仅限于 AMA 阳性血清。
我们认为 PBC 的胆道特异性是继发于胆道细胞凋亡的独特过程。